Literature DB >> 16308208

Generation of immunoliposomes using recombinant single-chain Fv fragments bound to Ni-NTA-liposomes.

Ronny Rüger1, Dafne Müller, Alfred Fahr, Roland E Kontermann.   

Abstract

Recombinant single-chain Fv antibody fragments (scFv) can be combined with liposomes to generate immunoliposomes for targeted drug delivery. Recent studies have shown that scFv molecules modified to express a C-terminal cysteine residue can be used for site-directed chemical conjugation. Here, we present a new method by immobilizing scFv fragments via their C-terminal hexahistidyl-tag on liposomes containing Ni-NTA-lipids (Ni-NTA-DOGS) in their lipid bilayer without the need to introduce additional reactive groups in the protein. Using an anti-endoglin scFv as a model antibody, we could show that scFv molecules are efficiently immobilized on the liposome surface and that these immunoliposomes bind specifically and strongly to endoglin-expressing endothelial cells. This approach allows for a rapid and flexible generation of target cell-specific immunoliposomes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16308208     DOI: 10.1080/10611860500353328

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  7 in total

1.  Surface functionalization of polyketal microparticles with nitrilotriacetic acid-nickel complexes for efficient protein capture and delivery.

Authors:  Jay C Sy; Edward A Phelps; Andrés J García; Niren Murthy; Michael E Davis
Journal:  Biomaterials       Date:  2010-03-25       Impact factor: 12.479

Review 2.  The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.

Authors:  W W Cheng; T M Allen
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

3.  Influence of multivalent nitrilotriacetic acid lipid-ligand affinity on the circulation half-life in mice of a liposome-attached His6-protein.

Authors:  Virginia Platt; Zhaohua Huang; Limin Cao; Matthew Tiffany; Kareen Riviere; Francis C Szoka
Journal:  Bioconjug Chem       Date:  2010-05-19       Impact factor: 4.774

4.  Dataset on FAP-induced emergence of spontaneous metastases and on the preparation of activatable FAP-targeting immunoliposomes to detect the metastases.

Authors:  Felista L Tansi; Ronny Rüger; Claudia Böhm; Roland E Kontermann; Ulf K Teichgraeber; Alfred Fahr; Ingrid Hilger
Journal:  Data Brief       Date:  2016-09-03

5.  Targeting the Tumor Microenvironment with Fluorescence-Activatable Bispecific Endoglin/Fibroblast Activation Protein Targeting Liposomes.

Authors:  Felista L Tansi; Ronny Rüger; Ansgar M Kollmeier; Markus Rabenhold; Frank Steiniger; Roland E Kontermann; Ulf K Teichgräber; Alfred Fahr; Ingrid Hilger
Journal:  Pharmaceutics       Date:  2020-04-17       Impact factor: 6.321

6.  Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response.

Authors:  Mesha Saeed; Sara Zalba; Ann L B Seynhaeve; Reno Debets; Timo L M Ten Hagen
Journal:  Int J Nanomedicine       Date:  2019-03-26

7.  Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody.

Authors:  Mesha Saeed; Mandy van Brakel; Sara Zalba; Erik Schooten; Joost A P Rens; Gerben A Koning; Reno Debets; Timo L M Ten Hagen
Journal:  Int J Nanomedicine       Date:  2016-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.